|
The client was developing a compound in a
new therapeutic area and wanted to ensure that the clinical
program provided the claim structure required for market
success.
In addition, the client needed a detailed understanding
of how competitors had
implemented clinical development programs historically.
The client also wanted to talk with
key opinion leaders (KOLs) to determine what enhancements
should be considered in the
future.
Specifically, the client wanted to know if one development
strategy resulted in faster
development and approval timelines relative to others.
|
MattsonJack's Science and Technology Assessment and Marketing
Research practice specialties combined to provide a
clinical review of currently marketed products, including
critical development issues, timelines and information
for future programs. |
